Contemporary management of primary parapharyngeal space tumors.

paraganglioma parapharyngeal tumors pleomorphic adenoma schwannoma transcervical approach

Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
02 2019
Historique:
received: 17 02 2018
revised: 19 06 2018
accepted: 06 07 2018
pubmed: 15 12 2018
medline: 10 9 2020
entrez: 15 12 2018
Statut: ppublish

Résumé

The parapharyngeal space is a complex anatomical area. Primary parapharyngeal tumors are rare tumors and 80% of them are benign. A variety of tumor types can develop in this location; most common are salivary gland neoplasm and neurogenic tumors. The management of these tumors has improved greatly owing to the developments in imaging techniques, surgery, and radiotherapy. Most tumors can be removed with a low rate of complications and recurrence. The transcervical approach is the most frequently used. In some cases, minimally invasive approaches may be used alone or in combination with a limited transcervical route, allowing large tumors to be removed by reducing morbidity of expanded approaches. An adequate knowledge of the anatomy and a careful surgical plan is essential to tailor management according to the patient and the tumor. The purpose of the present review was to update current aspects of knowledge related to this more challenging area of tumor occurrence.

Identifiants

pubmed: 30549361
doi: 10.1002/hed.25439
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

522-535

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Fernando López (F)

Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, CIBERONC, Oviedo, Spain.

Carlos Suárez (C)

Instituto de Investigación Sanitaria del Principado de Asturias, Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, CIBERONC, Oviedo, Spain.

Vincent Vander Poorten (V)

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium.
Department of Oncology, Section Head and Neck Oncology, University Hospitals Leuven, Leuven, Belgium.

Antti Mäkitie (A)

Department of Otorhinolaryngology, Head and Neck Surgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Iain J Nixon (IJ)

NHS Lothian, University of Edinburgh, Edinburgh, United Kingdom.

Primož Strojan (P)

Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia.

Ehab Y Hanna (EY)

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Juan Pablo Rodrigo (JP)

Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, CIBERONC, Oviedo, Spain.

Remco de Bree (R)

Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

Miquel Quer (M)

Department of Otolaryngology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.

Robert P Takes (RP)

Department of Otolaryngology-Head and Neck Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.

Carol R Bradford (CR)

Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan.

Ashok R Shaha (AR)

Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, New York.

Alvaro Sanabria (A)

Department of Surgery, School of Medicine, Universidad de Antioquia, Clínica Vida/Instituto de Cancerología Las Américas, Medellín, Colombia.

Alessandra Rinaldo (A)

University of Udine School of Medicine, Udine, Italy.

Alfio Ferlito (A)

Coordinator of the International Head and Neck Scientific Group.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH